menu

Obstructive Sleep Apnea (OSA) Screening Made Simple: Effective Strategies for Healthcare Professionals

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Obstructive Sleep Apnea (OSA) Screening Made Simple: Effective Strategies for Healthcare Professionals

5 episodes
0.50 program credits
35m
MinuteCE®
ReachMD Healthcare Image
Restart
Resume
Choose a format
Take Program Post-Test
Program Post-Test Completed
0.50 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Episodes
Presenters
Documents
Comments
  • Overview

    One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing symptoms of OSA, and you can make a difference. OSA screening is a missed opportunity in the primary care setting and can be easily implemented to ensure that the necessary steps are taken to get the patients into treatment and to improve patient outcomes. The purpose of this educational program is to help primary care providers learn how to screen for OSA, implement an OSA screening process, and develop a road map for cross-specialty collaborative relationships between sleep specialists and primary care clinicians.

  • Target Audience

    This activity has been designed to meet the educational needs of the interprofessional team, which includes Family Practice and Internal Medicine Clinicians, as well as other healthcare providers involved in managing patients with Obstructive Sleep Apnea (OSA).

  • Learning Objectives

    After participating in this educational activity, participants should be better able to: 

    • Understand the link between OSA and chronic disease
    • Develop strategies to integrate routine OSA screening into primary care practice, considering the current barriers and challenges
  • Accreditation and Credit Designation Statements

    In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and Total CME, LLC. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 0.5 nursing contact hour.  Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 0.5 CEUs of pharmacy contact hours.   

    The Universal Activity Number for this program is JA0006235-0000-24-041-H01-P. This learning activity is knowledge based.  Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service at custserv@napb.net 

  • Disclosure of Relevant Financial Relationships

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs. 

    The following faculty have disclosed:

    Alcibiades J. Rodriguez, MD, FAASM, faculty for this educational event, has no relevant financial relationships with ineligible companies. 

    Kevin Trice, MD, faculty for this educational event, receives research funds from Norton Healthcare; receives consulting fees for Jazz, Harmony, Axsome, and Indorsia; and is a patent holder for Pulmonary Apps, LLC. 

    Michael E. Yurcheshen, MD, FAASM, faculty for this educational event, receives research funds from Harmony Biosciences; and has an ownership interest in Voluware, Inc.

    Seema Khosla, MD, FCCP, FAASM, faculty for this educational event, receives consulting fees from Jazz; and has ownership interest in Inspire, Jazz and Avadel. 

    Anne Marie Morse, DO, FAASM, faculty for this educational event, receives research support from Geisinger Health Plan and UCB pharmaceuticals; receives consulting fees from Avadel, Jazz, Takeda, Alkermes and Harmony; and is a CEO/founder for DAMM Good Sleep, LLC. 

  • Planners and Managers Disclosure List

    The following reviewers, managers, planners, and relevant staff reported they do not have any financial relationships with any ineligible companies:

    Alison S. Kole, MD, MPH, FCCP, FAASM

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Total CME, LLC. This presentation is not intended to define an exclusive course of patient management; the participant should use their clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of MedEd On The Go you are subject to the terms and conditions of use, including copyright and licensing restrictions, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • Provider(s)/Educational Partner(s)

    Jointly provided by the American Academy of Sleep Medicine, Global Learning Collaborative, Inc., and Total CME, LLC.

  • Commercial Support

    The Count On Sleep program is led by the AASM and its key partner, the Sleep Research Society. Collaborating organizations include the Alliance of Sleep Apnea Partners, American Academy of Dental Sleep Medicine, American Academy of Otolaryngology – Head and Neck Surgery, American College of Chest Physicians, American Society for Metabolic and Bariatric Surgery, American Thoracic Society, and the National Sleep Foundation.

    This program was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the U.S. government.

  • Instructions

    During the period 3/29/2024 through 3/29/2025, registered participants wishing to receive continuing education credit for this activity must follow these steps:
    1. Read the learning objectives and faculty disclosures.
    2. Answer a pre-program question.
    3. View the program.
    4. Complete the post-test with a score of 100%. 
    5. Complete activity evaluation.
    6. Apply for credit and either bank your credits or print your certificate.

    For Pharmacists: Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Schedule29 May 2024